Home / Mesothelioma.net / 21-Month Follow-Up Data for Mesothelioma Drug Indicates Long-Term Survival

21-Month Follow-Up Data for Mesothelioma Drug Indicates Long-Term Survival

Just days after being granted FastTrack status by the U.S. Food and Drug Administration, Targovax released the latest clinical data...

from Mesothelioma.net https://ift.tt/3khvVup
via IFTTT
21-Month Follow-Up Data for Mesothelioma Drug Indicates Long-Term Survival 21-Month Follow-Up Data for Mesothelioma Drug Indicates Long-Term Survival Reviewed by Unknown on February 23, 2021 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.